Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Fludarabine + Mitoxantrone in Follicular NHL
NCT00185445Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jun 2004
- Primary completion
- Oct 2006
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fludarabine in follicular lymphoma (FL), sponsored by Sanofi. Primary endpoint: Complete Response Rate. Started Jun 2004; status: completed.
02
Drugs
fludarabine
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00185445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00185445.